ABSTRACT
Se expone la trayectoria de la vacuna conjugada antimeningocócica frente a N. meningitidisserogrupo C en los países que la han introducido en sus calendarios, en cuanto a pautasde utilización y al seguimiento de la efectividad clínica. A la vista de la disminución dela efectividad con el tiempo transcurrido desde la recepción de la vacuna, especialmente eninmunizados como lactantes, se comentan las distintas estrategias y pautas de vacunaciónfuturas
Concise review about different immunization schedules with polysaccharide-protein conjugatevaccines against serogroup C N meningitidis in various countries. Regarding some decreasein effectiveness months after its administration, particularly in vaccinated as infants,the author discusses possible schedules in the near future
Subject(s)
Male , Female , Infant , Child , Child, Preschool , Humans , Neisseriaceae Infections/prevention & control , Vaccines, Conjugate/administration & dosage , Meningococcal Vaccines/administration & dosage , Neisseria meningitidis/pathogenicity , Meningitis, Meningococcal/epidemiologyABSTRACT
No disponible
Subject(s)
Humans , Mass Vaccination/methods , Chickenpox Vaccine/administration & dosage , Disease Susceptibility , Patient Selection , Chickenpox/prevention & controlSubject(s)
Humans , Male , Female , Child , Immunization Programs/methods , Immunization Programs/standards , Immunization Programs , Public Health/methods , Public Health/standards , Immunization Programs/organization & administration , Immunization Programs/trends , Costs and Cost Analysis/trends , Cost Efficiency Analysis , Role PlayingABSTRACT
No disponible
Subject(s)
Child, Preschool , Infant , Humans , Haemophilus influenzae type b , Immunologic Memory , Haemophilus Vaccines , Antibodies, BacterialABSTRACT
En esta segunda parte se revisan los conocimientos actuales relativos a las perspectivas sobre enfermedades infecciosas prevalentes, la inmunización terapéutica y las estrategias para mejorar la adherencia a los programas de vacunación (AU)
Subject(s)
Pregnancy , Animals , Child , Child, Preschool , Male , Infant, Newborn , Female , Humans , Vaccines , Vaccination/trends , Immunization , Risk Factors , Viral Vaccines , Immunization Programs , Clinical Trials, Phase III as Topic , Vaccines, DNA , Patient Compliance , Alzheimer Vaccines , Bacterial Vaccines , Clinical Trials as Topic , Immunization Schedule , Forecasting , Preventive Health ServicesABSTRACT
No disponible
